148 results on '"Shen, Sherry"'
Search Results
2. Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancer
3. The Role of Obesity and Inflammation in Breast Cancer Recurrence
4. HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer
5. Looking beyond carboplatin and paclitaxel for the treatment of advanced/recurrent endometrial cancer
6. Sequential use of PI3K/AKT/mTOR pathway inhibitors alpelisib and everolimus in patients with hormone receptor-positive (HR+) metastatic breast cancer.
7. Glucagon-like peptide-1 (GLP-1) agonist use and weight change among patients with breast cancer.
8. Overall survival analysis of first line CDK4/6 inhibitors in a large real-world cohort of patients with hormone receptor-positive (HR+)/HER2-negative metastatic breast cancer.
9. Evolutionary continuity and divergence of auditory dorsal and ventral pathways in primates revealed by ultra-high field diffusion MRI
10. Reorganizing a Medicine Residency Program in Response to the COVID-19 Pandemic in New York
11. Incidence, risk factors, and management of alpelisib‐associated hyperglycemia in metastatic breast cancer
12. Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927)
13. P13-037-23 Changes in Dietary Patterns Among Breast Cancer Survivors Using a Mobile Behavior Change Program for Weight Loss: A Prospective Single-Arm Pilot Study
14. Abstract OT2-17-02: The ARETHA Study: A phase 2 randomized control trial of Eribulin with Evexomostat (SDX-7320) or placebo for patients with metastatic triple-negative breast cancer and metabolic dysfunction
15. Abstract P5-08-07: Dietary patterns among women with early-stage breast cancer from the Healthy Living Program
16. The Optimal Living Program: Integrating Exercise Into Cancer Care
17. Insulin-Lowering Diets in Metastatic Cancer
18. Characterization of alpelisib-associated hyperglycemia in metastatic breast cancer.
19. Clinicopathologic and molecular features associated with response to anti-HER2 therapy in endometrial cancer.
20. Targeting insulin feedback to enhance alpelisib (TIFA): A phase II randomized trial in metastatic, PIK3CA-mutant, hormone receptor–positive breast cancer.
21. Layout-Based 3D Solid Modeling of IC Structures and Interconnects Including Electrical Parameter Extraction
22. Obesity and Breast Cancer Risk: The Oncogenic Implications of Metabolic Dysregulation
23. Abstract P1-09-05: Baseline dietary patterns among women with newly diagnosed early-stage breast cancer enrolled in the Optimal Living Program
24. Challenging “Citizen Science”: Liminal Status Students and Community-Engaged Research
25. Chromatographic and spectroscopic studies on the chiral recognition of sulfated β-cyclodextrin as chiral mobile phase additive: Enantiomeric separation of a chiral amine
26. Sustained response to lenvatinib and pembrolizumab in two patients with KRAS-mutated endometrial mesonephric-like adenocarcinoma
27. Sulfated [beta]-Cyclodextrin as Chiral Mobile Phase Additive for Ultrahigh-Pressure Liquid Chromatography
28. Low Subcutaneous Adiposity and Mortality in Esophageal Cancer
29. Feasibility of a digital medicine program in optimizing opioid pain control in cancer patients (SWOG S1916).
30. Association between nonadherence to cardiovascular risk factor medications after breast cancer diagnosis and incidence of cardiac events
31. Adiposity and Endometrial Cancer.
32. Association of Cardiovascular Risk Factors With Cardiac Events and Survival Outcomes Among Patients With Breast Cancer Enrolled in SWOG Clinical Trials
33. Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).
34. Epimerization reaction of a substituted vinylcyclopropane catalyzed by ruthenium carbenes: Mechanistic analysis
35. Mucosal melanoma: epidemiology, biology, management and the role of immunotherapy
36. Abstract 2637: Impact of pre-diagnosis weight loss on outcomes in a prospective cohort of esophageal cancer patients
37. The ARETHA study: A phase 2 randomized control trial of eribulin with evexomostat (SDX-7320) or placebo for patients with metastatic triple-negative breast cancer (TNBC) and metabolic dysfunction.
38. Early integration of exercise into breast cancer care: The MSK healthy living program.
39. Prevalence and patterns of breast white adipose tissue inflammation among American Black women and indigenous Nigerian women with early-stage breast cancer.
40. Evaluation of a mobile behavior change program for weight loss in breast cancer survivors: A prospective single-arm pilot study.
41. Next-generation Sequencing Revealed a Novel Mutation in the Gene Encoding the Beta Subunit of Rod Phosphodiesterase
42. Bilateral Concordance of the Fundus Hyperautofluorescent Ring in Typical Retinitis Pigmentosa Patients
43. Development of a Safe and Economical Synthesis of Methyl 6-Chloro-5-(trifluoromethyl)nicotinate: Trifluoromethylation on Kilogram Scale
44. Zinc Catalyzed and Mediated Asymmetric Propargylation of Trifluoromethyl Ketones with a Propargyl Boronate
45. Development of a Large Scale Asymmetric Synthesis of the Glucocorticoid Agonist BI 653048 BS H3PO4
46. A Highly Convergent and Efficient Synthesis of a Macrocyclic Hepatitis C Virus Protease Inhibitor BI 201302
47. Vibrational circular dichroism of amylose carbamate: structure and solvent-induced conformational changes
48. Preparative Synthesis via Continuous Flow of 4,4,5,5-Tetramethyl-2-(3-trimethylsilyl-2-propynyl)-1,3,2-dioxaborolane: A General Propargylation Reagent
49. Asymmetric Synthesis of Sulfinamides Using (−)-Quinine as Chiral Auxiliary
50. Enantioselective Synthesis of Diverse Sulfinamides and Sulfinylferrocenes from Phenylglycine-Derived Chiral Sulfinyl Transfer Agent
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.